MeiraGTx Holdings: Gaining Regulatory Focus
MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.
JCN Newswire4h
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
HONG KONG, Mar 25, 2025 - (ACN Newswire) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, "CanSinoBIO" or the “Company”), a leading player in China's vaccine industry, achieved significant ...
Rest of World on MSN12h
Careem’s CEO wants to transform the ride-hailing giant into a “digital butler” for everyday life
Mudassir Sheikha, who co-founded the Middle East-based ride-hailing giant, on Careem’s new chapter, its recipe for winning ...